Emma E. Hamilton-Williams, PhD, described results from the TOGeTHER Trial of type 1 diabetes patients, who were treated with a specially modified dietary fiber designed to deliver short-chain fatty acids into the large intestine. Her presentation details the impact of the supplement on the gut bacteria and the diabetes management of trial participants, revealing a promising new avenue for type 1 diabetes therapy.
ICYMI: Presenter Perspectives: Manipulating the Gut Microbiome to Treat Diabetes
